FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064986515> ?p ?o ?g. }

• W2064986515 endingPage "74" @default.
• W2064986515 startingPage "67" @default.
• W2064986515 abstract "For non-small cell lung cancer (NSCLC) patients at stage IB, adjuvant chemotherapy does not improve survival. Evidence suggests that dendritic cell (DC)-activated cytokine-induced killer (DC-CIK) cell therapy in addition to chemotherapy improves survival for stage I‐IIIA NSCLC patients after surgery, but there are not enough data to confirm this benefit specifically for those at stage IB. Herein, we retrospectively evaluated the efficacy and safety of this therapy administered to stage IB NSCLC patients. Sixty-six patients were treated with four-cycle adjuvant chemotherapy initiated 3 weeks after surgical resection. In addition, 28 of these patients underwent DC-CIK therapy on a trimonthly basis (average 3.1 times, range 1‐6) beginning 1 month after chemotherapy. The disease-free survival (DFS) rates of the two groups were statistically similar, although patients who received DC-CIK therapy showed slightly higher 1- and 2-year DFS rates (100.0% and 96.4%, respectively, compared with 81.6% and 76.3%). More importantly, patients in the DC-CIK therapy group had significantly longer overall survival ( p = 0.018). For patients who received treatment after recurrence, the DC-CIK therapy group had longer progression-free survival compared with the chemotherapy-only group. In addition, patients given DC-CIK therapy experienced less fatigue and appetite loss. The rate of adverse side effects was similar between the two groups. In conclusion, for these stage IB NSCLC patients, DC-CIK therapy significantly improved 2-year DFS rates compared with those who received chemotherapy only. DC-CIK therapy also benefited patients’ quality of life, and adverse events were acceptable." @default.
• W2064986515 created "2016-06-24" @default.
• W2064986515 creator A5053326897 @default.
• W2064986515 creator A5064080819 @default.
• W2064986515 creator A5071654004 @default.
• W2064986515 creator A5071821976 @default.
• W2064986515 creator A5074339191 @default.
• W2064986515 date "2015-02-09" @default.
• W2064986515 modified "2023-10-18" @default.
• W2064986515 title "Adjuvant Chemotherapy With Sequential Cytokine-Induced Killer (CIK) Cells in Stage IB Non-Small Cell Lung Cancer" @default.
• W2064986515 cites W1967367784 @default.
• W2064986515 cites W1968626722 @default.
• W2064986515 cites W1974673444 @default.
• W2064986515 cites W1974712478 @default.
• W2064986515 cites W1997925829 @default.
• W2064986515 cites W2040602030 @default.
• W2064986515 cites W2042702383 @default.
• W2064986515 cites W2044758690 @default.
• W2064986515 cites W2050749285 @default.
• W2064986515 cites W2059679895 @default.
• W2064986515 cites W2067963226 @default.
• W2064986515 cites W2104504726 @default.
• W2064986515 cites W2128724028 @default.
• W2064986515 cites W2133114658 @default.
• W2064986515 cites W2135577165 @default.
• W2064986515 cites W2138032761 @default.
• W2064986515 cites W2139919192 @default.
• W2064986515 cites W2144031118 @default.
• W2064986515 cites W2150034934 @default.
• W2064986515 cites W2167571044 @default.
• W2064986515 cites W4232026175 @default.
• W2064986515 doi "https://doi.org/10.3727/096504014x14024160459168" @default.
• W2064986515 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7838450" @default.
• W2064986515 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25706393" @default.
• W2064986515 hasPublicationYear "2015" @default.
• W2064986515 type Work @default.
• W2064986515 sameAs 2064986515 @default.
• W2064986515 citedByCount "19" @default.
• W2064986515 countsByYear W20649865152016 @default.
• W2064986515 countsByYear W20649865152017 @default.
• W2064986515 countsByYear W20649865152018 @default.
• W2064986515 countsByYear W20649865152019 @default.
• W2064986515 countsByYear W20649865152020 @default.
• W2064986515 countsByYear W20649865152021 @default.
• W2064986515 countsByYear W20649865152022 @default.
• W2064986515 countsByYear W20649865152023 @default.
• W2064986515 crossrefType "journal-article" @default.
• W2064986515 hasAuthorship W2064986515A5053326897 @default.
• W2064986515 hasAuthorship W2064986515A5064080819 @default.
• W2064986515 hasAuthorship W2064986515A5071654004 @default.
• W2064986515 hasAuthorship W2064986515A5071821976 @default.
• W2064986515 hasAuthorship W2064986515A5074339191 @default.
• W2064986515 hasBestOaLocation W20649865151 @default.
• W2064986515 hasConcept C114684123 @default.
• W2064986515 hasConcept C126322002 @default.
• W2064986515 hasConcept C141071460 @default.
• W2064986515 hasConcept C143998085 @default.
• W2064986515 hasConcept C146357865 @default.
• W2064986515 hasConcept C151730666 @default.
• W2064986515 hasConcept C167672396 @default.
• W2064986515 hasConcept C203014093 @default.
• W2064986515 hasConcept C2776256026 @default.
• W2064986515 hasConcept C2776283816 @default.
• W2064986515 hasConcept C2776694085 @default.
• W2064986515 hasConcept C2777863537 @default.
• W2064986515 hasConcept C2777982462 @default.
• W2064986515 hasConcept C2779109515 @default.
• W2064986515 hasConcept C71924100 @default.
• W2064986515 hasConcept C86803240 @default.
• W2064986515 hasConcept C8891405 @default.
• W2064986515 hasConcept C90924648 @default.
• W2064986515 hasConceptScore W2064986515C114684123 @default.
• W2064986515 hasConceptScore W2064986515C126322002 @default.
• W2064986515 hasConceptScore W2064986515C141071460 @default.
• W2064986515 hasConceptScore W2064986515C143998085 @default.
• W2064986515 hasConceptScore W2064986515C146357865 @default.
• W2064986515 hasConceptScore W2064986515C151730666 @default.
• W2064986515 hasConceptScore W2064986515C167672396 @default.
• W2064986515 hasConceptScore W2064986515C203014093 @default.
• W2064986515 hasConceptScore W2064986515C2776256026 @default.
• W2064986515 hasConceptScore W2064986515C2776283816 @default.
• W2064986515 hasConceptScore W2064986515C2776694085 @default.
• W2064986515 hasConceptScore W2064986515C2777863537 @default.
• W2064986515 hasConceptScore W2064986515C2777982462 @default.
• W2064986515 hasConceptScore W2064986515C2779109515 @default.
• W2064986515 hasConceptScore W2064986515C71924100 @default.
• W2064986515 hasConceptScore W2064986515C86803240 @default.
• W2064986515 hasConceptScore W2064986515C8891405 @default.
• W2064986515 hasConceptScore W2064986515C90924648 @default.
• W2064986515 hasIssue "2" @default.
• W2064986515 hasLocation W20649865151 @default.
• W2064986515 hasLocation W20649865152 @default.
• W2064986515 hasOpenAccess W2064986515 @default.
• W2064986515 hasPrimaryLocation W20649865151 @default.
• W2064986515 hasRelatedWork W1668400678 @default.
• W2064986515 hasRelatedWork W2387957804 @default.
• W2064986515 hasRelatedWork W2401392746 @default.
• W2064986515 hasRelatedWork W2413020017 @default.

• next